In the last trading session, 1.34 million MoonLake Immunotherapeutics (NASDAQ:MLTX) shares changed hands as the company’s beta touched 1.32. With the company’s per share price
In last trading session, MoonLake Immunotherapeutics (NASDAQ:MLTX) saw 0.33 million shares changing hands with its beta currently measuring 1.31. Company’s recent per share price level
MoonLake Immunotherapeutics (NASDAQ:MLTX)’s traded shares stood at 0.43 million during the last session, with the company’s beta value hitting 1.36. At the close of trading,
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
